Micro Emerging Active

UBSはJasper Therapeuticsをカバー開始

New narrative with limited coverage — still forming.

スコア
0.4
勢い
▲ 0.0
記事
4
情報源
1

Sentiment Timeline

Event Timeline

4月 07, 2026
Evercore ISI Lowers its Price Target on Jasper Therapeutics (JSPR) to $7 Bearish
4月 06, 2026
UBS Upgrades JFrog (FROG) to Buy with $60 Price Target on Demand … Bullish
3月 30, 2026
Edgewise Therapeutics, Inc. (EWTX) PT Increased to $45 at JPMorgan Amid Optimism … Bullish
3月 29, 2026
Why UBS Started Jasper Therapeutics (JSPR) at Neutral Despite Progress in Briquilimab Neutral

タイムライン

初回検出3月 29, 2026
最終更新3月 29, 2026